Dexcom Selected as First Participant in FDA TEMPO Pilot Program
San Diego, July 22, 2026 Dexcom announced that it has become the first company selected by the U.S. Food...
Prediabetes
Advertisement
Cambrian Bio Reports Positive Phase 1b ATX-304 Data
NEW YORK, N.Y. | June 18, 2026 Cambrian Bio has presented positive Phase 1b clinical data for ATX-304, the...
1 in 5 U.S. Donors Show Prediabetes, Diabetes Risk
February 25, 2026 – Washington, D.C., USA New nationwide screening data from the American Red Cross shows that 1...
Advertisement
